Moffitt Cancer Center announces collaboration with AstraZeneca
Moffitt Cancer Center has agreed to a strategic collaboration with AstraZeneca, to accelerate the development of cell therapies, specifically chimeric antigen receptor T cell and T cell receptor therapies. AstraZeneca will have priority access to Moffitt’s clinical environment and create connections between physician-scientists to advance the investigation of novel cell therapies. The collaboration aims to … Read more